Morris-Stiff G et al. |
Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases. |
1998 |
Transplant. Proc. |
pmid:9636525
|
Claesson K et al. |
Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients. |
1998 |
Transplant. Proc. |
pmid:9636524
|
Vanrenterghem Y et al. |
Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636523
|
Mendez R |
FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636522
|
Morris-Stiff G et al. |
Pharmaco-economic study of FK 506 (Prograf) and cyclosporine A Neoral in cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636521
|
Rostaing L et al. |
Influence of early FK 506 trough levels on glomerular hemodynamics at 3 months in kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636520
|
Rostaing L et al. |
Early posttransplantation renal hemodynamics in FK 506-treated kidney recipients with or without prior induction therapy. |
1998 |
Transplant. Proc. |
pmid:9636519
|
Uchida K et al. |
Decreasing pancreatic toxicity of tacrolimus by dosage reduction. |
1998 |
Transplant. Proc. |
pmid:9636518
|
Sato S et al. |
Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636517
|
Christiaans M et al. |
Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636516
|
van Duijnhoven E et al. |
The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation. |
1998 |
Transplant. Proc. |
pmid:9636515
|
van Duijnhoven E et al. |
Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data. |
1998 |
Transplant. Proc. |
pmid:9636514
|
Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
Undre NA and Schäfer A |
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. |
1998 |
Transplant. Proc. |
pmid:9636512
|
Jordan ML et al. |
Tacrolimus for rescue of refractory renal allograft rejection. |
1998 |
Transplant. Proc. |
pmid:9636511
|
Copley JB et al. |
Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts. |
1998 |
Transplant. Proc. |
pmid:9636510
|
Kliem V et al. |
Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9636509
|
Loss GE et al. |
Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. |
1998 |
Transplant. Proc. |
pmid:9636508
|
Busque S et al. |
Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636507
|
Morris-Stiff G et al. |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report. |
1998 |
Transplant. Proc. |
pmid:9636506
|
Fernando ON et al. |
Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636505
|
Friemann S et al. |
Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636504
|
Budde K et al. |
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. |
1998 |
Transplant. Proc. |
pmid:9636503
|
Carl S et al. |
Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept. |
1998 |
Transplant. Proc. |
pmid:9636502
|
Turner CD et al. |
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. |
1998 |
Transplant. Proc. |
pmid:9636501
|
Eghtesad B et al. |
Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. |
1998 |
Transplant. Proc. |
pmid:9636500
|
Morris-Stiff G et al. |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636499
|
Kinukawa T et al. |
Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. |
1998 |
Transplant. Proc. |
pmid:9636498
|
Tanabe K et al. |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636497
|
Braun F et al. |
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636496
|
Takahashi K et al. |
Tacrolimus therapy for ABO-incompatible kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636495
|
Jensik SC |
Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636494
|
Preston R et al. |
FK 506 as primary immunosuppressive therapy in renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636493
|
Miura S et al. |
Effect of tacrolimus on the outcome of renal transplantation with donor-specific blood transfusion. |
1998 |
Transplant. Proc. |
pmid:9636492
|
Fritsche L et al. |
Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. |
1998 |
Transplant. Proc. |
pmid:9636481
|
Marcus N et al. |
Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636460
|
Stempfle HU et al. |
Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636459
|
Walker RE et al. |
Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9636452
|
Undre NA et al. |
Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636451
|
Rieber J et al. |
Effects of tacrolimus and cyclosporine on the coronary microcirculation after heart transplantation: a prospective study with serial intracoronary flow measurements. |
1998 |
Transplant. Proc. |
pmid:9636446
|
Kobashigawa JA |
Controversies in heart and lung transplantation immunosuppression: tacrolimus versus cyclosporine. |
1998 |
Transplant. Proc. |
pmid:9636445
|
Miki T et al. |
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. |
1998 |
Transplant. Proc. |
pmid:9636444
|
Li S et al. |
Intrathymic inoculation of donor bone marrow at the time of transplantation plus a short course of tacrolimus induce long-term acceptance to rat lung allografts. |
1998 |
Transplant. Proc. |
pmid:9636431
|
Chen H et al. |
FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouse. |
1998 |
Transplant. Proc. |
pmid:9636419
|
Yura H et al. |
Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9636416
|
Yoshimura N et al. |
Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9636415
|
Fujimura T et al. |
Cellular surface molecular and cytokine gene expression in rat heart allografts under optimal doses of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636413
|
Isobe M et al. |
Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase. |
1998 |
Transplant. Proc. |
pmid:9636407
|
McAlister VC |
Liposomal tacrolimus: drug migration within blood compartments. |
1998 |
Transplant. Proc. |
pmid:9636404
|
Krüger B et al. |
Different effects of cyclosporine or tacrolimus on hepatocyte acute phase proteins. |
1998 |
Transplant. Proc. |
pmid:9636399
|
Silber RE et al. |
Comparison of the effect of FK 506 and alpha/beta-T-cell antibody R73 on transplant vascular sclerosis after heterotopic rat heart transplantation. |
1998 |
Transplant. Proc. |
pmid:9636398
|
Müller V et al. |
Effect of mycophenolate mofetil on the in vivo infiltration of lymphocytes in the rat remnant kidney. |
1998 |
Transplant. Proc. |
pmid:9636396
|
Hutchinson IV et al. |
Differences in the mode of action of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636388
|
Ginevri F et al. |
Expression of collagen by renal fibroblasts treated with FK 506 in vitro. |
1998 |
Transplant. Proc. |
pmid:9636387
|
Nicholson ML et al. |
Is TGF-beta a profibrotic cytokine in human renal transplants? |
1998 |
Transplant. Proc. |
pmid:9636384
|
Tredger JM et al. |
Therapeutic monitoring of tacrolimus (FK506) with the first- and second-generation microparticle enzyme immunoassays: performance and results in four patient populations. |
1998 |
Ther Drug Monit |
pmid:9631923
|
Al-Awwa IA et al. |
Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis. |
1998 |
Am. J. Kidney Dis. |
pmid:9631859
|
Starzl TE et al. |
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. |
1998 |
Am. J. Kidney Dis. |
pmid:9631858
|
Ellouk-Achard S et al. |
FK506 (Tacrolimus) decreases the cytotoxicity of cyclosporin A in rat hepatocytes in primary culture: implication of CYP3A induction. |
1998 |
Arch. Toxicol. |
pmid:9630010
|
Takada Y et al. |
Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. |
1998 |
Surgery |
pmid:9626320
|
Pruvot FR and Noel C |
Comment on "Pregnancy after liver transplantation under tacrolimus" by Jain et al. |
1998 |
Transplantation |
pmid:9625033
|
Schulman SL et al. |
Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. |
1998 |
Transplantation |
pmid:9625026
|
Lampen A et al. |
Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. |
1998 |
Xenobiotica |
pmid:9622846
|
Kikuchi M et al. |
Protective effects of FK506 against glutamate-induced neurotoxicity in retinal cell culture. |
1998 |
Invest. Ophthalmol. Vis. Sci. |
pmid:9620083
|
Idilman R et al. |
Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant. |
1998 |
Eur J Gastroenterol Hepatol |
pmid:9619393
|
Tomás ML |
[Immunosuppressive agents: side effects]. |
1997 |
An R Acad Nac Med (Madr) |
pmid:9616947
|
Samsó M and Wagenknecht T |
Contributions of electron microscopy and single-particle techniques to the determination of the ryanodine receptor three-dimensional structure. |
1998 |
J. Struct. Biol. |
pmid:9615436
|
Kliem V and Brunkhorst R |
Tacrolimus in kidney transplantation. A clinical review. |
1998 |
Nephron |
pmid:9609456
|
Ito H et al. |
Myoblast transplantation in non-dystrophic dog. |
1998 |
Neuromuscul. Disord. |
pmid:9608563
|
Singer NG and McCune WJ |
Update on immunosuppressive therapy. |
1998 |
Curr Opin Rheumatol |
pmid:9608317
|
Tomono M et al. |
Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. |
1998 |
Arch. Biochem. Biophys. |
pmid:9606972
|
Tomura N et al. |
Transient neurotoxicity associated with FK506: MR findings. |
1998 May-Jun |
J Comput Assist Tomogr |
pmid:9606397
|
Homey B et al. |
Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. |
1998 |
J. Immunol. |
pmid:9605132
|
Chang RK et al. |
Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation. |
1998 |
Am. J. Cardiol. |
pmid:9604971
|
Capone D et al. |
Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients. |
1998 |
J Chemother |
pmid:9603651
|
Shapiro R et al. |
Alopecia as a consequence of tacrolimus therapy. |
1998 |
Transplantation |
pmid:9603186
|
Beatty PR et al. |
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. |
1998 |
Transplantation |
pmid:9603175
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Oyanagui Y |
Immunosuppressants enhance superoxide radical/nitric oxide-dependent dexamethasone suppression of ischemic paw edema in mice. |
1998 |
Eur. J. Pharmacol. |
pmid:9600660
|
Hueros G et al. |
A maize FK506-sensitive immunophilin, mzFKBP-66, is a peptidylproline cis-trans-isomerase that interacts with calmodulin and a 36-kDa cytoplasmic protein. |
1998 |
Planta |
pmid:9599809
|
Wagner R et al. |
32-Ascomycinyloxyacetic acid derived immunosuppressants. Independence of immunophilin binding and immunosuppressive potency. |
1998 |
J. Med. Chem. |
pmid:9599228
|
Koyama T et al. |
[Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation]. |
1998 |
Jpn J Antibiot |
pmid:9597507
|
Gregory CR |
Immunosuppressive approaches to the prevention of graft vascular disease. |
1998 |
Transplant. Proc. |
pmid:9595134
|
Weis M et al. |
Impact of immunosuppression on coronary endothelial function after cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9595131
|
Marone G et al. |
Immunopharmacology of human mast cells and basophils. |
1998 |
Int. J. Clin. Lab. Res. |
pmid:9594358
|
Wakita H et al. |
Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. |
1998 |
Brain Res. |
pmid:9593846
|
Hebebrand D et al. |
Limb xenotransplantation using FK506 and RS61443 immunosuppression. |
1998 |
J Reconstr Microsurg |
pmid:9590615
|
Chiba K et al. |
FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. |
1998 |
J. Immunol. |
pmid:9590253
|
Kadry Z et al. |
Kaposi's sarcoma in liver transplant recipients on FK506. |
1998 |
Transplantation |
pmid:9583882
|
Muraki T et al. |
Effects of cyclosporine and FK506 on in vitro high shear-induced platelet reactivity in rat and human non-anticoagulated blood. |
1998 |
Transplantation |
pmid:9583878
|
Zervos XA et al. |
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplantation |
pmid:9583863
|
Abu-Elmagd K et al. |
Clinical intestinal transplantation: new perspectives and immunologic considerations. |
1998 |
J. Am. Coll. Surg. |
pmid:9583691
|
Cardoso CM et al. |
Uncoupling of Ca2+ transport ATPase in muscle and blood platelets by diacylglycerol analogues and cyclosporin A antagonism. |
1997 |
Biochem. J. |
pmid:9581558
|
Sugi-Ikai N et al. |
Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. |
1998 |
Invest. Ophthalmol. Vis. Sci. |
pmid:9579479
|
Sakane T |
[Physiopathology and therapy of Behcet's syndrome]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9577569
|
Miyasaka N |
[Recent findings on etiological mechanism of autoimmune diseases]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9577564
|
Barinaga M |
Signaling path may lead to better heart-failure therapies. |
1998 |
Science |
pmid:9575084
|
Matsuda T et al. |
Involvement of calcineurin in Ca2+ paradox-like injury of cultured rat astrocytes. |
1998 |
J. Neurochem. |
pmid:9572286
|
Finney NS |
Enantioselective epoxide hydrolysis: catalysis involving microbes, mammals and metals. |
1998 |
Chem. Biol. |
pmid:9571210
|
Araki T et al. |
Post-ischemic alterations in [3H]FK506 binding in the gerbil and rat brains. |
1998 |
Metab Brain Dis |
pmid:9570636
|